| Ms Julie Marie Layton, MA, CCC-SLP | |
|
300 Floyd Dr, Sikeston, MO 63801-3960 | |
| (573) 472-0397 | |
| (573) 472-0409 |
| Full Name | Ms Julie Marie Layton |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 300 Floyd Dr, Sikeston, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275637761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2001026968 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Julie Marie Layton, MA, CCC-SLP 495 Matt Ln, Jackson, MO 63755-8531 Ph: (573) 204-1702 | Ms Julie Marie Layton, MA, CCC-SLP 300 Floyd Dr, Sikeston, MO 63801-3960 Ph: (573) 472-0397 |
News Archive
The National Center for Regenerative Medicine (NCRM) at Case Western Reserve University is proud to present "MSC 2011: Innovations in Cell-Based Regenerative Therapies," a three-day forum to highlight transformative breakthroughs in the area of adult stem cell medicine with a focus on how this research is being applied in patient care settings through innovative clinical trials.
Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.
A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.
Nearly 9 million people in UK suffer from debilitating headaches called migraine and this leads to a severe impairment in quality of life and affects productivity. The headaches associated with an attack may last for several days often bringing nausea and a general feeling of uneasiness in presence of lights and sounds.
› Verified 9 days ago
Ashton Glascock, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 | |
Mrs. Angela Dawn Jackson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 603 Ashley Dr, Sikeston, MO 63801 Phone: 573-471-6653 | |
Chelsea Rodgers, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1102 Sikes Ave, Sikeston, MO 63801 Phone: 573-471-5755 | |
Melissa Phillips, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 S Kingshighway St, Sikeston, MO 63801 Phone: 573-471-0110 Fax: 573-472-1880 | |
Lashea Worley, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 Glenn Dr, Sikeston, MO 63801 Phone: 573-472-5360 | |
Mrs. Christy Lea Jaynes, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Annah J Voshage, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 |